Advertisement

Topics

Hopes are up: A Second Phase III Trial for Alzheimer’s Disease

11:36 EST 28 Feb 2017 | Labiotech.eu

The Swiss biotech AC Immune announced that its partner Genentech (Roche) will start a second phase III clinical trial for its Alzheimer’s therapy crenezumab. In 2006 AC Immune partnered up with Genentech to bring its amyloid beta (Aβ)-targeting antibody crenezumab into the clinic. Although the ...

This awesome article Hopes are up: A Second Phase III Trial for Alzheimer’s Disease appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Hopes are up: A Second Phase III Trial for Alzheimer’s Disease

NEXT ARTICLE

More From BioPortfolio on "Hopes are up: A Second Phase III Trial for Alzheimer’s Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...